S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RA Capital Management/Q1 2021

RA Capital Management

Period: Q1 2021 Β· Filed: 2021-05-17
View on SEC EDGAR β†—
AUM
$6.63B
Total portfolio value
Positions
82
Reported securities
Top Holding
ASND
12.5% $826.4M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2021-05-17) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ASNDASCENDIS PHARMA A/S$826.4M12.46%$128.88$274.50+113.0%
12.5%
NVAXNOVAVAX INC$544.3M8.21%$181.31$9.74-94.6%
8.2%
VORXXXXVOR BIOPHARMA INC$479.3M7.23%β€”β€”
7.2%
AVIRATEA PHARMACEUTICALS INC$331.5M5.00%$61.75$4.98-91.9%
5.0%
FMTXFORMA THERAPEUTICS HLDGS INC$252.5M3.81%β€”β€”
3.8%
TGTXTG THERAPEUTICS INC$223.5M3.37%$48.20$53.31+10.6%
3.4%
NKTXNKARTA INC$184.4M2.78%$32.90$3.22-90.2%
2.8%
CCXICHEMOCENTRYX INC$182.3M2.75%β€”$19.10
2.8%
MGNXMACROGENICS INC$157.1M2.37%$31.85$4.71-85.2%
2.4%
ITOSITEOS THERAPEUTICS INC$151.0M2.28%β€”β€”
2.3%
IMGNIMMUNOGEN INC$149.2M2.25%β€”β€”
2.3%
TVTXTRAVERE THERAPEUTICS INC$140.2M2.11%$24.97$56.92+128.0%
2.1%
TILINSTIL BIO INC$122.2M1.84%$501.60$7.73-98.5%
1.8%
PHATPHATHOM PHARMACEUTICALS INC$117.0M1.76%$37.56$11.20-70.2%
1.8%
ETNB89BIO INC$112.2M1.69%β€”β€”
1.7%
KNTEKINNATE BIOPHARMA INC$112.0M1.69%β€”β€”
1.7%
RYTMRHYTHM PHARMACEUTICALS INC$103.6M1.56%$21.27$114.17+436.8%
1.6%
ZGNXZOGENIX INC$103.1M1.56%β€”β€”
1.6%
AXSMAXSOME THERAPEUTICS INC$93.7M1.41%$56.62$244.31+331.5%
1.4%
RCKTROCKET PHARMACEUTICALS INC COM$93.5M1.41%$44.37$3.84-91.3%
1.4%
ADVMADVERUM BIOTECHNOLOGIES INC$92.3M1.39%β€”β€”
1.4%
EWTXEDGEWISE THERAPEUTICS INC$84.9M1.28%$32.50$39.56+21.7%
1.3%
CRISCURIS INC$80.8M1.22%$226.40$6.93-96.9%
1.2%
BOLTBOLT BIOTHERAPEUTICS INC$78.3M1.18%$658.20$4.05-99.4%
1.2%
PCVXVAXCYTE INC$76.3M1.15%$19.75$58.39+195.7%
1.1%
MCRBSERES THERAPEUTICS INC$76.1M1.15%$411.80$7.74-98.1%
1.1%
SPRYSILVERBACK THERAPEUTICS INC$76.0M1.15%$43.63$8.56-80.4%
1.1%
IGMSIGM BIOSCIENCES INC$75.4M1.14%β€”β€”
1.1%
KALAKALA PHARMACEUTICALS INC$73.3M1.11%$16850.00$1.68-100.0%
1.1%
OLMAOLEMA PHARMACEUTICALS INC$71.3M1.08%$33.18$12.64-61.9%
1.1%

Quarter-on-Quarter Activity

Q1 2021 vs. Q4 2020

New Positions (8)

TickerIssuerNotionalSince Filing
VORXXXXVOR BIOPHARMA INC$479.3M
TILINSTIL BIO INC$122.2M-98.5%
EWTXEDGEWISE THERAPEUTICS INC$84.9M+21.7%
BOLTBOLT BIOTHERAPEUTICS INC$78.3M-99.4%
MCRBSERES THERAPEUTICS INC$76.1M-98.1%
DSGNDESIGN THERAPEUTICS INC$65.4M
CNTBXXXXCONNECT BIOPHARMA HLDGS LTD$55.3M
CTMXCYTOMX THERAPEUTICS INC$27.1M

Exited Positions (8)

TickerIssuerNotional
ARVNARVINAS INC$311.9M
KROSKEROS THERAPEUTICS INC$132.3M
FPRXFIVE PRIME THERAPEUTICS INC$72.9M
INBXINHIBRX INC$70.2M
LEGNLEGEND BIOTECH CORP$67.8M
CRDFCARDIFF ONCOLOGY INC$59.2M
PACBPACIFIC BIOSCIENCES OF CALIFORNIA INC$51.6M
ARQTARCUTIS BIOTHERAPEUTICS INC$32.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CNCECONCERT PHARMACEUTICALS INC$-7.9M+66.4%
STSASATSUMA PHARMACEUTICALS INC$13.4M+26.3%
SLDBSOLID BIOSCIENCES INC$-7.2M+24.0%
TVTXTRAVERE THERAPEUTICS INC$16.0M+23.2%+128.0%
CNSTCONSTELLATION PHARMCETICLS INC$-1.0M+20.8%
RYTMRHYTHM PHARMACEUTICALS INC$-20.6M+16.6%+436.8%
MGNXMACROGENICS INC$57.1M+12.8%-85.2%
ASNDASCENDIS PHARMA A/S$-151.8M+9.3%+113.0%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
TGTXTG THERAPEUTICS INC$-228.4M-46.6%+10.6%
CCXICHEMOCENTRYX INC$-113.5M-25.5%
SCPHSCPHARMACEUTICALS INC$-0.5M-22.4%
NVAXNOVAVAX INC$121.8M-20.8%-94.6%
PHATPHATHOM PHARMACEUTICALS INC$-10.1M-18.6%-70.2%
CRISCURIS INC$17.7M-7.4%-96.9%
MISTMILESTONE PHARMACEUTICALS INC$-2.6M-3.5%
ARYAARYA SCIENCES ACQUISITION CO$2.5M-2.9%
← Back to Hedge Funds
RA Capital Management Q1 2021 13F Filing β€” Holdings & Portfolio | MarketsFN